Electronic Clinical Outcome Assessment Solutions Market Size, Share & Trends Analysis Report By Delivery Mode (Web & Cloud Based, On-premise), By End-user, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global electronic clinical outcome assessment solutions market size was valued at USD 1.36 billion in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.2% from 2023 to 2030. An increasing number of clinical trials, the need to improve compliance, effectively capture and manage clinical information, the need to reduce costs, and increasing R&D activities, are the factors expected to drive the growth of the market. In December 2020, Kayentis- a French company specializing in electronic clinical outcome assessment (eCOA) solutions received funding of about USD 8.3 million. This facilitated its objectives for regional expansion and product development.

COVID-19 adversely impacted the conduction and management of clinical trials in 2020. However, market stakeholders implemented several measures such as the adoption of eClinical solutions to overcome these challenges and to ensure the continuity of clinical research activities. The pandemic thus helped catalyze the digitalization of clinical trials.

Many sponsors, Biopharma companies, medical device firms, & CROs began adopting eClinical solutions to collect data, manage it, and draw useful insights effectively and remotely. Electronic clinical outcomes assessments (eCOAs) support the collection of patient data remotely. This helped investigators and sponsors track patient progress during the pandemic. The trend is anticipated to continue post-COVID.

The rising adoption of eCOA by medical research professionals is driving market growth. With the rising number of research studies, the need for a centralized data capture system that helps improve patient engagement is also increasing. This is anticipated to fuel market demand during r the forecast period. The use of electronic patient-reported outcomes (ePROs) has emerged as a helpful tool during COVID-19 to collect and share important trial data, and to use other embedded tools such as alerts and reminders to weave the trial into the daily lives of the patients. This boosts patient engagement. Technological advancements such as Alexa-style tools, reward features, and gamification are estimated to enhance eCOA products thus driving market growth in the future.

In addition, the rising burden on pharmaceutical manufacturers to cut down overall costs for new drug development procedures has resulted in their rising inclination toward electronic data capturing from paper-based procedures. The data capturing via eCOA platforms improve the quality of the information received, harmonizes the data collection procedures, and offers significant value to its users, such as data analysis.

Electronic-based services for data capturing & analyzing meet all the challenges of paper-based records, with an increase in patient compliance. They also eliminate the risk of data variance and minimize the site monitoring cost. Streamlined information offered by these solutions helps improvise the data quality by collecting the information in a structured way. These aforementioned benefits with the use of eCOA are expected to drive demand for the products in the coming years.

Delivery Mode Insights

Web & cloud-based segments contributed to the largest revenue share of the eCOA solutions market by delivery mode in 2022. This is owing to the associated benefits of its usage. Remote access to the patient’s health information and sharing of the information to limit potential misuse of the data or address the problems at a critical point of study are some of the key features offered by these solutions. Other benefits include centralization of data, scalability, reduced costs, and uptime consistency.

On-premise solutions, on the other hand, may be preferred for their localization of data, data security, and more control over data. The high cost of implementation and infrastructure may restrain the segment growth. An increasing number of companies and initiatives deployed by them are expected to fuel market growth. Some of the key companies include IBM, IQVIA Inc., Medidata Solutions, Inc., Clario, ArisGlobal, Signant Health, and others.

End-user Insights

Contract research organizations (CROs) held the largest revenue share in 2021 and are expected to witness significant growth in the near future due to the outsourcing of clinical research management by major biopharmaceutical and medical device companies. IQVIA eCOA for example supports real-time patient data collection in real-world studies and clinical research. During the COVID-19 the solution was deployed across several trials to enable real-time data capture, cost-effectively and remotely.

Hospitals and healthcare providers are adopting electronic data-capturing services to improve patient engagement in research studies, as eCOA digitally collects information from both patients and doctors. eCOA captures information on handheld devices such as smartphones & tablets, interactive voice response systems, browsers, and patients’ Bring-Your-Own-Device (BYOD).

It utilizes secure systems that meet the regulatory guidelines for capturing clinical data. The adoption of mHealth devices and the introduction of advanced technologies for patient care, such as BYOD, are the key growth propellers for the implementation of eCOA solutions in hospitals.

Regional Insights

North America was estimated to be the largest regional market in 2022. The presence of technologically advanced research centers, medical device manufacturers, universities, and hospitals coupled with improved healthcare establishments are expected to drive new drug development activities in the coming years. The U.S. accounted for the largest market share of North America in 2022, owing to the higher adoption levels of eClinical solutions.

Initiatives and acquisitions pertaining to the adoption of eClinical platforms undertaken by key end-users and market players are anticipated to boost usage in the coming years. For instance, the press release from Dacima in July 2022 stated that EvidentIQ acquired Dacima. As a result, the EvidentIQ Group now has access to Dacima's broad service offering for end-to-end eClinical solutions which includes eCOA.

Asia Pacific is growing in terms of large patient pools, outsourcing, and the flow of investment by MNCs and CROs to support clinical research and drug discovery. This is projected to enhance the market growth. India and China are the key markets for clinical research outsourcing for major pharma & biotech companies. This is anticipated to be a key contributing factor toward the rising demand for eCOA solutions during the forecast period.

Key Companies & Market Share Insights

The electronic clinical outcome assessment (eCOA) solutions market is competitive with the presence of many companies. These are involved in implementing strategic initiatives that include up gradation of software and services, customer acquisition, partnerships & collaborations, mergers & acquisitions, and sales & marketing activities.

For instance, in June 2021, Assistek launched an upgraded version of its cloud-based electronic clinical outcome assessment (eCOA) platform. The upgraded version includes enhancements for clinical teams, sponsors, patients, and CROs. It is designed to align with best practices for the collection of clinical outcomes in a secure manner. IBM’s Clinical Development suite on the other hand offers a comprehensive solution for clinical data management serving a wide range of user types. It includes electronic clinical outcome assessment (eCOA) that replaces standard reporting methods and enhances clinical outcomes.

Furthermore, THREAD acquired Modus Outcomes in November 2021. With this purchase, THREAD is following through on its plan to offer its clients the most comprehensive eCOA solution possible by utilizing M&A. Some of the key players in the global electronic clinical outcome assessment solutions market include:

• IBM

• IQVIA Inc.

• Medidata Solutions, Inc.

• Clario

• ArisGlobal

• Signant Health

• TransPerfect

• Cloudbyz

• Clime do Health GmbH

• ClinCapture

Electronic Clinical Outcome Assessment Solutions Market Report Scope

Global Electronic Clinical Outcome Assessment Solutions Market Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global electronic clinical outcome assessment solutions market report based on the delivery mode, end-user, and region:

• Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

  • On-premise

  • Web & Cloud-based

• End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals/Healthcare Providers

  • CROs

  • Pharmaceutical & Biotechnology Firms

  • Medical Device Companies

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

    • Saudi Arabia